Harel Insurance Investments & Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-933
| Closed | -$390K | – | 733 |
|
|
2020
Q4 | $390K | Hold |
933
| – | – | 0.01% | 397 |
|
|
2020
Q3 | $136K | Buy |
+933
| New | +$136K | ﹤0.01% | 358 |
|
|
2020
Q1 | – | Sell |
-572
| Closed | -$66K | – | 434 |
|
|
2019
Q4 | $66K | Buy |
572
+440
| +333% | +$50.8K | ﹤0.01% | 338 |
|
|
2019
Q3 | $11K | Hold |
132
| – | – | ﹤0.01% | 434 |
|
|
2019
Q2 | $10K | Sell |
132
-2,000
| -94% | -$152K | ﹤0.01% | 422 |
|
|
2019
Q1 | $210K | Sell |
2,132
-185
| -8% | -$18.2K | 0.01% | 121 |
|
|
2018
Q4 | $169K | Buy |
2,317
+39
| +2% | +$2.85K | 0.01% | 187 |
|
|
2018
Q3 | $200K | Buy |
2,278
+1,953
| +601% | +$171K | 0.01% | 201 |
|
|
2018
Q2 | $32K | Hold |
325
| – | – | ﹤0.01% | 348 |
|
|
2018
Q1 | $39K | Sell |
325
-95
| -23% | -$11.4K | ﹤0.01% | 327 |
|
|
2017
Q4 | $53K | Buy |
420
+230
| +121% | +$29K | ﹤0.01% | 317 |
|
|
2017
Q3 | $22K | Buy |
+190
| New | +$22K | ﹤0.01% | 334 |
|
|
2016
Q4 | – | Sell |
-210
| Closed | -$14K | – | 370 |
|
|
2016
Q3 | $14K | Sell |
210
-20
| -9% | -$1.33K | ﹤0.01% | 351 |
|
|
2016
Q2 | $13K | Buy |
230
+80
| +53% | +$4.52K | ﹤0.01% | 525 |
|
|
2016
Q1 | $9K | Hold |
150
| – | – | ﹤0.01% | 363 |
|
|
2015
Q4 | $14K | Buy |
+150
| New | +$14K | ﹤0.01% | 278 |
|